Table of Contents

2019-2024 Global RNA Vaccines Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Vaccines Consumption 2014-2024
2.1.2 RNA Vaccines Consumption CAGR by Region
2.2 RNA Vaccines Segment by Type
2.2.1 Individualized Cancer Treatment MRNA Vaccine
2.2.2 Infectious Disease Treatment MRNA Vaccine
2.2.3 Infection Prevention MRNA Vaccine
2.3 RNA Vaccines Consumption by Type
2.3.1 Global RNA Vaccines Consumption Market Share by Type (2014-2019)
2.3.2 Global RNA Vaccines Revenue and Market Share by Type (2014-2019)
2.3.3 Global RNA Vaccines Sale Price by Type (2014-2019)
2.4 RNA Vaccines Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.4.3 Other
2.5 RNA Vaccines Consumption by Application
2.5.1 Global RNA Vaccines Consumption Market Share by Application (2014-2019)
2.5.2 Global RNA Vaccines Value and Market Share by Application (2014-2019)
2.5.3 Global RNA Vaccines Sale Price by Application (2014-2019)

3 Global RNA Vaccines by Players
3.1 Global RNA Vaccines Sales Market Share by Players
3.1.1 Global RNA Vaccines Sales by Players (2017-2019)
3.1.2 Global RNA Vaccines Sales Market Share by Players (2017-2019)
3.2 Global RNA Vaccines Revenue Market Share by Players
3.2.1 Global RNA Vaccines Revenue by Players (2017-2019)
3.2.2 Global RNA Vaccines Revenue Market Share by Players (2017-2019)
3.3 Global RNA Vaccines Sale Price by Players
3.4 Global RNA Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global RNA Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players RNA Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 RNA Vaccines by Regions
4.1 RNA Vaccines by Regions
4.1.1 Global RNA Vaccines Consumption by Regions
4.1.2 Global RNA Vaccines Value by Regions
4.2 Americas RNA Vaccines Consumption Growth
4.3 APAC RNA Vaccines Consumption Growth
4.4 Europe RNA Vaccines Consumption Growth
4.5 Middle East & Africa RNA Vaccines Consumption Growth

5 Americas
5.1 Americas RNA Vaccines Consumption by Countries
5.1.1 Americas RNA Vaccines Consumption by Countries (2014-2019)
5.1.2 Americas RNA Vaccines Value by Countries (2014-2019)
5.2 Americas RNA Vaccines Consumption by Type
5.3 Americas RNA Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC RNA Vaccines Consumption by Countries
6.1.1 APAC RNA Vaccines Consumption by Countries (2014-2019)
6.1.2 APAC RNA Vaccines Value by Countries (2014-2019)
6.2 APAC RNA Vaccines Consumption by Type
6.3 APAC RNA Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe RNA Vaccines by Countries
7.1.1 Europe RNA Vaccines Consumption by Countries (2014-2019)
7.1.2 Europe RNA Vaccines Value by Countries (2014-2019)
7.2 Europe RNA Vaccines Consumption by Type
7.3 Europe RNA Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa RNA Vaccines by Countries
8.1.1 Middle East & Africa RNA Vaccines Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa RNA Vaccines Value by Countries (2014-2019)
8.2 Middle East & Africa RNA Vaccines Consumption by Type
8.3 Middle East & Africa RNA Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 RNA Vaccines Distributors
10.3 RNA Vaccines Customer

11 Global RNA Vaccines Market Forecast
11.1 Global RNA Vaccines Consumption Forecast (2019-2024)
11.2 Global RNA Vaccines Forecast by Regions
11.2.1 Global RNA Vaccines Forecast by Regions (2019-2024)
11.2.2 Global RNA Vaccines Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global RNA Vaccines Forecast by Type
11.8 Global RNA Vaccines Forecast by Application

12 Key Players Analysis
12.1 Moderna Therapeutics
12.1.1 Company Details
12.1.2 RNA Vaccines Product Offered
12.1.3 Moderna Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Moderna Therapeutics News
12.2 CureVac
12.2.1 Company Details
12.2.2 RNA Vaccines Product Offered
12.2.3 CureVac RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 CureVac News
12.3 Translate Bio
12.3.1 Company Details
12.3.2 RNA Vaccines Product Offered
12.3.3 Translate Bio RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Translate Bio News
12.4 BioNTech
12.4.1 Company Details
12.4.2 RNA Vaccines Product Offered
12.4.3 BioNTech RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 BioNTech News
12.5 Sangamo Therapeutics
12.5.1 Company Details
12.5.2 RNA Vaccines Product Offered
12.5.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Sangamo Therapeutics News
12.6 Argos Therapeutics
12.6.1 Company Details
12.6.2 RNA Vaccines Product Offered
12.6.3 Argos Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Argos Therapeutics News
12.7 In-Cell-Art
12.7.1 Company Details
12.7.2 RNA Vaccines Product Offered
12.7.3 In-Cell-Art RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 In-Cell-Art News
12.8 eTheRNA
12.8.1 Company Details
12.8.2 RNA Vaccines Product Offered
12.8.3 eTheRNA RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 eTheRNA News
12.9 Ethris
12.9.1 Company Details
12.9.2 RNA Vaccines Product Offered
12.9.3 Ethris RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Ethris News
12.10 Tiba Biotechnology
12.10.1 Company Details
12.10.2 RNA Vaccines Product Offered
12.10.3 Tiba Biotechnology RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Tiba Biotechnology News

13 Research Findings and Conclusion